Differential formation of β-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3379-3383

  Mei, Jay M ^a   Hord, Norman G ^a,c   Winterstein, Dolores F ^b   Donald, Steven P ^a   Phang, James M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DNA; LYMPHOID ENHANCER FACTOR 1;

ANIMAL CELL; ARTICLE; COLON CANCER; COLON POLYPOSIS; COMPLEX FORMATION; CONCENTRATION RESPONSE; CROHN DISEASE; DNA BINDING; DNA PROTEIN COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ANIMALS; BETA CATENIN; CELL LINE, TRANSFORMED; CELL NUCLEUS; COLON; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; GENES, APC; GENOTYPE; INTESTINAL MUCOSA; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRO COMPOUNDS; PENICILLAMINE; S-NITROSO-N-ACETYLPENICILLAMINE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0034234979     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Morin, P. J., Sparks, A. B., Krinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-oatenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science (Washington DC), 275: 1787-1790, 1997.
2. Moser, A. R., Pitot, H. C., and Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (Washington DC), 247: 322-324, 1990.
3. Sheng, H., Shao, J., Williams, C. S., Pereira, M. A., Taketa, M. M., Oshima, M., Reynolds, A. B., Washington, M. K., DuBois, R. N., and Beauchamp, R. D. Nuclear translocation of β-catenin in hereditary and carcinogen-induced intestinal adenomas. Carcinogenesis (Lond.), 19: 543-549, 1998.
4. Korinck, V., Barker, N., Morin, P. J., Van Wichen, D., De Weger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. Constitutive transcriptional activation by β-catenin-Tcf complex in APC-/-colon carcinoma. Science (Washington DC), 275: 1784-1787, 1997.
5. Rubinfeld, B., Souza, B., Albert, I., Muller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., and Polakis, P. Association of the Apc gene product with β-catenin. Science (Washington DC), 262: 1731-1734, 1995.
6. ter Steege, J., Buurman, W., Arends, J. W., and Forget, P. Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab. Investig., 77: 29-36, 1997.
7. Singer, I. I., Kawka, D. W., Scott, S., Weidner, J. R., Mumford, R. A., Richl, T. E., and Stenson, W. F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonie epithelium in inflammatory bowel disease. Gastroenterology, 111: 871-885, 1996.
8. Ambs, S., Merriam, W. G., Bennett, W. P., Felley-Bosco, E., Ogunfusika, M. O., Oser, S., Klein, S., Shields, P. G., Billiar, T. R., and Harris, C. C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res., 58: 334-341, 1998.
9. Mei, J. M., Hord, N. G., Winterstein, D. F., Donald, S. P., and Phang, J. M. Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized colonic epithelial cells. FASEB J., 14: 1188-1201, 2000.
10. Whitehead, R. H., and Joseph, J. L. Derivation of conditionally immortalized cell lines containing the Min mutation from the normal colonie mucosa and other tissues of an "Immonomouse"/Min hybrid. Epithelial Cell Biol., 3: 119-125, 1994.
11. Whitehead, R. H., VanEeden, P. E., Nobel, M. D., Ataliotis, P., and Jat, P. S. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl. Acad. Sci. USA. 90: 587-591, 1993.
12. Mei, J. M., Hord, N. G., Winlerstein, D. F., Donald, S. P., and Phang, J. M. Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated β-catenin-LEF-1 transcription complex in mouse colonie epithelial cells contrasting in Apc. Carcinogenesis (Lond.), 20: 737-740, 1999.
13. D'Abaco, G. M., Whitehead, R. H., and Burgess, A. W. Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas. Mol. Cell. Biol., 3: 884-891, 1996.
14. Sakanaka, C., Weiss, J. B., and Williams, L. T. Bridging of β-catenin and glycogen synthase kinase-3 β by Axin and inhibition of β-catenin-mediated transcription. Proc. Natl. Acad. Sci. USA, 95: 3020-3023, 1998.
15. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., and Polakis, P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl. Acad. Sci. USA, 92: 3046-3050, 1995.
16. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi, A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex wilh GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J., 17: 1371-1384, 1998.
17. Kuroda, S., Fukata, M., Nakagawa, M., Fujii, K., Nakamura, T., Ookubo, T., Izawa, I., Nagase, T., Nomura, N., Tani, H., Shoji, I., Matsuura, Y., Yonehara, S., and Kaibuchi, K. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin-mediated cell-cell adhesion. Science (Washington DC), 281: 832-835, 1998.
18. Ryuto, M., Jimi, S., Ono, M., Naito, S., Nakayama, Y., Yamada, Y., Komiyama, S., and Kuwano, M. All-trans-retinoic acid-dependent inhibition of E-cadherin-based cell adhesion with concomitant dephosphorylation of β-catenin in metastatic human renal carcinoma cells. Jpn. J. Cancer Res., 88: 982-991, 1997.
19. Parrish, A. R., Catania, J. M., Orozco, J., and Gandolti, A. J. Chemically induced oxidative stress disrupts the E-cadherin/catenin cell adhesion complex. Toxicol. Sci., 51: 80-86, 1999.
20. Ito, K., Okamoto, I., Araki, N., Kawano, Y., Nakao, M., Fujiyama, S., Tomita, K., Mimori, T., and Saya, H. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of β-catenin from cell-cell contacts. Oncogene, 18: 7080-7090, 1999.
21. Sasaki, K., Hattori, T., Fujisawa, T., Takahashi, K., Inoue, H., and Takigawa, M. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J. Biochem., 123: 431-439, 1998.
22. Murell, G. A. G., Jang, D., and Williams, R. J. Nitric oxide activates metalloprolease enzymes in articular cartilage. Biochem. Biophys. Res. Commun., 206: 15-21, 1995.
23. 2+ changes in endothelial cells independent of cGMP. J. Cell Physiol., 172: 296-305, 1997.
24. Hirooka, K. Kourennyi, D. E., and Barnes, S. Calcium channel activation facilitated by nitric oxide in retinal ganglion cells. J. Neurophysiol. (Bethesda), 83: 198-206, 2000.
25. Mei, J. M., Chi, W. M., Trump, B. F., and Eccles, C. U. Involvement of nitric oxide in the deregulation of cytosolic calcium in cerebellar neurons during combined glucose-oxygen deprivation. Mol. Chem. Neuropathol., 27: 155-166, 1996.
26. Rao, C. V., Kawamori, T., Hamid, R., and Reddy, B. S. Chemoprevention of colonie aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis (Lond.), 20: 641-644, 1999.
27. Liu, J. H., and Hotchkiss, R. H. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res., 339: 73-89, 1995.
28. Yao, J., Schoecklmann, H. O., Prols, F., Gauer, S., and Sterzel, R. B. Exogenous nitric oxide inhibits mesangial cells adhesion to extracellular matrix components. Kidney Int., 53: 598-608, 1998.
29. Tamura, T., Nakanishi, T., Kimura, Y., Hattori, T., Sasaki, K., Norimatsu, H., Takahashi, K., Takigawa, M. Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology, 137: 3729-3737, 1996.